Clinical trial
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
NCT00071227 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00071227 |
|---|---|
| Title | Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders |
| Official title | Pilot Study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Retinal Vein Occlusion |
| Intervention type | Drug |
| Interventions | Triamcinolone Acetonide (TAC-PF) |
| Enrollment | 16 |
| Start date | Oct 15, 2003 |
| Completion | Aug 15, 2007 |
| First posted | Oct 16, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: